Trials / Recruiting
RecruitingNCT06676813
Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.
Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis(NASH), A Randomized Controlled Trial. FAST Trial"
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aims of this study are as follows: To compare the role of alternate-day fasting over standard medical management alone to reverse NASH.
Detailed description
Emerging evidence suggests the role of alternate-day fasting (ADF) in patients with obesity and fatty liver. It helps to lose weight and improvement in liver fat content. ADF regimen protocol includes fast day(restricted calorie intake and time-specific feeding) and feast day(ad libitum feed over 24 hours). Lowering the weight and improvement of the fatty liver. NASH is a prevalent cause of liver disease. Literature is evident that ADF improves fatty liver and metabolic components, and NASH improves with weight loss. Still, data about the role of ADF in the management of NASH is lacking. Hence, this study focuses on the role of ADF in NASH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Alternate day fasting | Alternate day fasting |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2024-11-06
- Last updated
- 2024-11-07
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT06676813. Inclusion in this directory is not an endorsement.